Can Aparito's Wearable Tech Solve Big Pharma's Billion-Dollar Crisis?

As many as 42% of pediatric clinical trials end up in failure and inconclusive results. "That means we don't know one way or the other if a drug works or not," says Aparito founder Elin Haf Davies. This isn't just a problem for the big pharma companies who are spending billions of dollars developing successful studies. It's a problem for you, the patient, who pays a mark up on medication to cover these costs--and for taxpayers supporting healthcare services like the NHS. "Society as a whole is losing out," notes Davies, a former research nurse for medical institutions like London's Great Ormond Street Hospital.